Targeted Next-Generation Sequencing Identifies Actionable Targets in Estrogen Receptor Positive and Estrogen Receptor Negative Endometriod Endometrial Cancer
Frontiers in Pharmacology - Switzerland
doi 10.3389/fphar.2018.00750
Full Text
Open PDFAbstract
Available in full text
Categories
Date
July 13, 2018
Authors
Publisher
Frontiers Media SA